Blog
It’s no secret that the top health concern on most Americans’ minds today is COVID-19 – a unprecedented disrupter like we’ve never seen before. However, as the pandemic rages on, many are trying to move forward and keep things in motion and retaining as much sense of normalcy as possible during these challenging times. There...
Cancer remains a leading cause of death among Americans with nearly two million newly diagnosed patients in 2018. As this trend continues, various...
Recently, there have been published reports stating that a large proportion of studies published in high-impact scientific journals could not be...
A sound preclinical plan coupled with expert oncology guidance can help identify biomarkers that can assist with patient selection—or help...
Too often, new drugs fail during development due to poor study design and inadequate knowledge about the performance of a new drug. A large part of...
If you’re exploring nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH) or cancer-associated liver fibrosis, you may want...
Ketogenic diets—which involve higher saturated fat, moderate protein and low carbohydrate consumption—have been successfully used to manage human...
Don’t skip important steps in preclinical research: drug metabolism and pharmacokinetic analysis (DMPK). DMPK Quick Tips More and more, researchers...
Often, new drug makers come across a potential anticancer agent—and as they consider evaluating that agent further, they tend to confront this...
Sometimes, the U.S. FDA is criticized as incapable in comparison with its European counterpart, the EMEA. Particularly this criticism is commonly...
Oncology drug development is important for numerous drug developers, funding bodies and academic researchers. This has caused a wealth of new...